NFKB1 and Alzheimer disease: For example, inhibition of CHI3L1 with the compound K284-6111 prevented amyloid beta-induced neuroinflammation and impairment of recognition memory via inhibition of the NF-κB pathway in an Alzheimer’s disease mouse model [42].